What does Drs. Depaepe-Latoir do?

Drs. Depaepe-Latoir is a specialist medical practice in Oosterzele. Private Limited, started on 7 January 2013, 2 establishments.

What is the address of Drs. Depaepe-Latoir?

The registered office of Drs. Depaepe-Latoir is located at Reigerstraat 33, 9860 Oosterzele.

Is Drs. Depaepe-Latoir still active?

Yes. According to the CBE (30 October 2026) Drs. Depaepe-Latoir is active, legal situation “Normale toestand”, started on 7 January 2013.

Is Drs. Depaepe-Latoir registered on Peppol?

Yes, Drs. Depaepe-Latoir is registered on the Peppol network with ID 0208:0502445152.

What is the enterprise number of Drs. Depaepe-Latoir?

The enterprise number of Drs. Depaepe-Latoir is BE0502445152.

When was Drs. Depaepe-Latoir founded?

Drs. Depaepe-Latoir was founded on 7 January 2013.

Who are the directors of Drs. Depaepe-Latoir?

According to the 2025 annual accounts, the directors of Drs. Depaepe-Latoir are: Yves Depaepe, Annelies Latoir.

Is Drs. Depaepe-Latoir a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2013; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Drs. Depaepe-Latoir make in 2025?

Drs. Depaepe-Latoir posted a profit after taxes of € 346,371 in financial year 2025.

What is the revenue of Drs. Depaepe-Latoir?

As a small company, Drs. Depaepe-Latoir is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 537,438.

How many employees does Drs. Depaepe-Latoir have?

According to the 2025 annual accounts, Drs. Depaepe-Latoir has 0.5 full-time equivalents (FTE).

Drs. Depaepe-Latoir (Private Limited) - Oosterzele

Dossier Drs. Depaepe-Latoir, printed on 30 October 2026 from databakkes.be/en/0502445152/drs-depaepe-latoir. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Drs. Depaepe-Latoir from Oosterzele, company number BE0502445152, closed financial year 2025 with a result of € 346,371 after tax. For that financial year Drs. Depaepe-Latoir recorded a gross margin of € 537,438 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 224,867 to € 346,371. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 23, 2026.

What it is worth Growing

€ 1.1 million

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 346,371

▲ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 685,071

▲ 91% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 57,166 paid out

17 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 21,380

▲ 6% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,406

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 39,189

▼ 22% vs 2024

€ 5,943 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 12,250

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 82,404

▼ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 259,351 Gross margin 2022: € 259,351 First fiscal year in the series	€ 407,625 Gross margin 2023: € 407,625 ▲ 57% vs 2022 (€ 259,351) Favourable step	€ 391,338 Gross margin 2024: € 391,338 ▼ 4% vs 2023 (€ 407,625) Unfavourable step	€ 537,438 Gross margin 2025: € 537,438 ▲ 37% vs 2024 (€ 391,338) Favourable step	▲ 37%
Profit after taxes	€ 107,821 Profit after taxes 2022: € 107,821 First fiscal year in the series	€ 211,609 Profit after taxes 2023: € 211,609 ▲ 96% vs 2022 (€ 107,821) Favourable step	€ 224,867 Profit after taxes 2024: € 224,867 ▲ 6% vs 2023 (€ 211,609) Favourable step	€ 346,371 Profit after taxes 2025: € 346,371 ▲ 54% vs 2024 (€ 224,867) Favourable step	▲ 54%
Equity	€ 355,108 Equity 2022: € 355,108 First fiscal year in the series	€ 565,117 Equity 2023: € 565,117 ▲ 59% vs 2022 (€ 355,108) Favourable step	€ 788,318 Equity 2024: € 788,318 ▲ 39% vs 2023 (€ 565,117) Favourable step	€ 1,077,523 Equity 2025: € 1,077,523 ▲ 37% vs 2024 (€ 788,318) Favourable step	▲ 37%
Total debts	€ 203,454 Total debts 2022: € 203,454 First fiscal year in the series	€ 192,138 Total debts 2023: € 192,138 ▼ 6% vs 2022 (€ 203,454) Favourable step	€ 168,472 Total debts 2024: € 168,472 ▼ 12% vs 2023 (€ 192,138) Favourable step	€ 135,009 Total debts 2025: € 135,009 ▼ 20% vs 2024 (€ 168,472) Favourable step	▼ 20%
Cash	€ 136,943 Cash 2022: € 136,943 First fiscal year in the series	€ 356,904 Cash 2023: € 356,904 ▲ 161% vs 2022 (€ 136,943) Favourable step	€ 359,121 Cash 2024: € 359,121 ▲ 1% vs 2023 (€ 356,904) Favourable step	€ 685,071 Cash 2025: € 685,071 ▲ 91% vs 2024 (€ 359,121) Favourable step	▲ 91%
Land & buildings	€ 40,609 Land & buildings 2022: € 40,609 First fiscal year in the series	€ 38,014 Land & buildings 2023: € 38,014 ▼ 6% vs 2022 (€ 40,609) Unchanged	€ 40,294 Land & buildings 2024: € 40,294 ▲ 6% vs 2023 (€ 38,014) Unchanged	€ 38,671 Land & buildings 2025: € 38,671 ▼ 4% vs 2024 (€ 40,294) Unchanged	▼ 4%
Retained profit	€ 342,708 Retained profit 2022: € 342,708 First fiscal year in the series	€ 552,717 Retained profit 2023: € 552,717 ▲ 61% vs 2022 (€ 342,708) Favourable step	€ 775,918 Retained profit 2024: € 775,918 ▲ 40% vs 2023 (€ 552,717) Favourable step	€ 1,065,123 Retained profit 2025: € 1,065,123 ▲ 37% vs 2024 (€ 775,918) Favourable step	▲ 37%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,600 Dividend 2023: € 1,600 Unchanged (€ 1,600) Unchanged	€ 1,666 Dividend 2024: € 1,666 ▲ 4% vs 2023 (€ 1,600) Unchanged	€ 57,166 Dividend 2025: € 57,166 ▲ € 55,500 vs 2024 (€ 1,666) Unchanged	▲ € 55,500
Bank debt	€ 106,105 Bank debt 2022: € 106,105 First fiscal year in the series	€ 64,571 Bank debt 2023: € 64,571 ▼ 39% vs 2022 (€ 106,105) Favourable step	€ 50,541 Bank debt 2024: € 50,541 ▼ 22% vs 2023 (€ 64,571) Favourable step	€ 39,189 Bank debt 2025: € 39,189 ▼ 22% vs 2024 (€ 50,541) Favourable step	▼ 22%
Balance sheet total	€ 558,561 Balance sheet total 2022: € 558,561 First fiscal year in the series	€ 757,255 Balance sheet total 2023: € 757,255 ▲ 36% vs 2022 (€ 558,561) Unchanged	€ 956,790 Balance sheet total 2024: € 956,790 ▲ 26% vs 2023 (€ 757,255) Unchanged	€ 1,212,531 Balance sheet total 2025: € 1,212,531 ▲ 27% vs 2024 (€ 956,790) Unchanged	▲ 27%
Employees (FTE)	-	0.5 Employees (FTE) 2023: 0.5 First fiscal year in the series	0.5 Employees (FTE) 2024: 0.5 Unchanged (0.5) Unchanged	0.5 Employees (FTE) 2025: 0.5 Unchanged (0.5) Unchanged

Key figures of Drs. Depaepe-Latoir, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Drs. Depaepe-Latoir?

What happened at Drs. Depaepe-Latoir in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 23, 2026 New annual accounts for financial year 2025: profit of € 346,371 (▲ 54% vs 2024). Source: NBB ↗
Jul 1, 2015 New establishment in Oosterzele. KBO
Jan 14, 2013 New establishment in Gavere. KBO
Jan 7, 2013 Start of the company according to the CBE. KBO

In short

From € 107,821 profit in 2022 to € 346,371 profit in 2025.

Paid € 403,183 in corporate taxes since 2022.

Best year ever: 2025, with € 346,371 profit.

Paid out € 62,032 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Yves Depaepe Annelies Latoir

Drs. Depaepe-Latoir

HUISARTSENKRING PANACEA

Huisartsen Houtem

Behind Drs. Depaepe-Latoir are Yves Depaepe and Annelies Latoir. Annelies Latoir is also behind HUISARTSENKRING PANACEA and Huisartsen Houtem.

Directors

According to the 2025 annual accounts

Yves Depaepe

Director

Annelies Latoir

Director

Also active at: HUISARTSENKRING PANACEA, Huisartsen Houtem

Establishments

Establishment units

Physical locations of this company

Registered office

Reigerstraat 33

9860 Oosterzele

2.216.166.720

Stationsstraat 43 box 1

9890 Gavere

Active since 14 January 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0502.445.152

VAT number

BE 0502.445.152

Registered office

Reigerstraat 33, 9860 Oosterzele

Names & denominations

Drs. Depaepe-Latoir

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 January 2013

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

Drs. Depaepe-Latoir

Financials

What happened to Drs. Depaepe-Latoir?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions